Antiviral activity of type I interferons and interleukins 29 and 28a (type III interferons) against Apeu virus

Antiviral Research

Volumn 80, Issue 3, 2008, Pages 302-308

  Almeida, Gabriel Magno de Freitas ^a   de Oliveira, Danilo Bretas ^a   Magalhães, Cintia Lopes de Brito ^a   Bonjardim, Cláudio Antônio ^a   Ferreira, Paulo César Peregrino ^a   Kroon, Erna Geessien ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antiviral; Apeu; Bunyaviridae; Interferon; Interleukin; Lambda

Indexed keywords

RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 28 A; RECOMBINANT INTERLEUKIN 29; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; APEU VIRUS; ARTICLE; BRAZIL; BUNYAVIRUS; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAIN FOREST; RECEPTOR BINDING;

ANIMALS; ANTIVIRAL AGENTS; BUNYAVIRIDAE INFECTIONS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE I; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; ORTHOBUNYAVIRUS; VERO CELLS;

APEU VIRUS; BUNYAVIRIDAE; ORTHOBUNYAVIRUS; RNA VIRUSES; VERTEBRATA;

EID: 56349138977     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.06.016     Document Type: Article

References (45)

1. Alcami A., and Smith G.L. The vaccinia virus soluble interferon-gamma receptor is a homodimer. J. Gen. Virol. 83 (2002) 545-549
2. Andersson I., Bladh L., Mousavi-Jazi M., Magnusson K.E., Lundkvist A., Haller O., and Mirazimi A. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J. Virol. 78 (2004) 4323-4329
3. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., and Paludan S.R. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80 (2006) 4501-4509
4. Bartlett N.W., Buttigieg K., Kotenko S.V., and Smith G.L. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J. Gen. Virol. 86 (2005) 1589-1596
5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. Suppl. 97 (1968) 77-89
6. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., Diebold J., Diepolder H., Adler B., Auernhammer C.J., Goke B., and Dambacher J. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) 960-968
7. Brand S., Zitzmann K., Dambacher J., Beigel F., Olszak T., Vlotides G., Eichhorst S.T., Göke B., Diepolder H., and Auernhammer C.J. SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem. Biophys. Res. Commun. 331 (2005) 543-548
8. Bridgen A., Dalrymple D.A., Weber F., and Elliott R.M. Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res. 99 (2004) 47-50
9. Calisher C.H. History, classification, and taxonomy of viruses in the family Bunyaviridae. In: Elliott R.M. (Ed). The Bunyaviridae (1996), Plenum Press, New York 1-17
10. Causey O.R., Causey C.E., Maroja O.M., and Macedo D.G. The isolation of arthropod-borne viruses, including members of two hitherto undescribed serological groups, in the Amazon region of Brazil. Am. J. Trop. Med. Hyg. 10 (1961) 227-249
11. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., Cella M., Lande R., and Uzé G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34 (2004) 796-805
12. De Mucha Macias J., Davalos Mata A., Ochoa Larios M.E., and Zarate Aquino M.L. Experimental infection using Apeu virus in mice (Mus musculus albinus). Histopathological injuries vol. 11 (1969), Salud Publica Mex. pp. 323-338
13. Diaz M.O., Ziemin S., Le Beau M.M., Pitha P., Smith S.D., Chilcote R.R., and Rowley J.D. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5259-5263
14. Dulbecco R., and Vogt M. Some problems of animal virology as studied by the plaque technique. Cold Spring Harb. Symp. Quant. Biol. 18 (1953) 273-279
15. Dumoutier L., Tounsi A., Michiels T., Sommereyns C., Kotenko S.V., and Renauld J.C. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J. Biol. Chem. 279 (2004) 32269-32274
16. Elliott R.M. Emerging viruses: the Bunyaviridae. Mol. Med. 3 (1997) 572-577
17. Ferreira P.C., Peixoto M.L., Silva M.A., and Golgher R.R. Assay of human interferon in Vero cells by several methods. J. Clin. Microbiol. 9 (1979) 471-475
18. Frese M., Kochs G., Feldmann H., Hertkorn C., and Haller O. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 70 (1996) 915-923
19. Gerrard S.R., Li L., Barrett A.D., and Nichol S.T. Ngari virus is a Bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa. J. Virol. 78 (2004) 8922-8926
20. Gibbs Jr. C.J., Bruckner E.A., and Schenker S. A case of Apeu virus infection. Am. J. Trop. Med. Hyg. 13 (1964) 108-113
21. Huang J., Smirnov S.V., Lewis-Antes A., Balan M., Li W., Tang S., Silke G.V., Putz M.M., Smith G.L., and Kotenko S.V. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 9822-9827
22. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147 (1957) 258-267
23. Jordan W.J., Eskdale J., Boniotto M., Rodia M., Kellner D., and Gallagher G. Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29). Genes Immun. 8 (2007) 13-20
24. Jordan W.J., Eskdale J., Srinivas S., Pekarek V., Kelner D., Rodia M., and Gallagher G. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun. 8 (2007) 254-261
25. Kanerva M., Melén K., Vaheri A., and Julkunen I. Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology 224 (1996) 55-62
26. Kochs G., Janzen C., Hohenberg H., and Haller O. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3153-3158
27. Kontsek P., Karayianni-Vasconcelos G., and Kontseková E. The human interferon system: characterization and classification after discovery of novel members. Acta Virol. 47 (2003) 201-215
28. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., and Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4 (2003) 69-77
29. Krause C.D., and Pestka S. Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol. Ther. 106 (2005) 299-346
30. Livonesi M.C., de Sousa R.L., Badra S.J., and Figueiredo L.T. In vitro and in vivo studies of the Interferon-alpha action on distinct Orthobunyavirus. Antiviral Res. 75 (2007) 121-128
31. Meager A., Visvalingam K., Dilger P., Bryan D., and Wadhwa M. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 31 (2005) 109-118
32. Mennechet F.J., and Uzé G. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107 (2006) 4417-4423
33. Morrill J.C., Jennings G.B., Cosgriff T.M., Gibbs P.H., and Peters C.J. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Rev. Infect. Dis. 11 Suppl. 4 (1989) S815-S825
34. Pestka S., Krause C.D., and Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202 (2004) 8-32
35. Petrillo-Peixoto M.L., Ferreira P.C., Mezencio J.M., and Golgher R.R. Sensitivity of group C arboviruses (bunyaviridae) to human amnion interferon. Intervirology 14 (1980) 16-20
36. Pinto A.J., Morahan P.S., Brinton M., Stewart D., and Gavin E. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J. Interferon Res. 10 (1990) 293-298
37. Robek M.D., Boyd B.S., and Chisari F.V. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol. 79 (2005) 3851-3854
38. Sato A., Ohtsuki M., Hata M., Kobayashi E., and Murakami T. Antitumor activity of IFN-lambda in murine tumor models. J. Immunol. 176 (2006) 7686-7694
39. Schmaljohn C.S., and Hooper J.W. In: Fields B.N., Knipe B.N., and Fields Virology D.M. (Eds). The Bunyaviridae. 4th ed. (2001), Lippincott Williams & Wilkins, Philadelphia 1581-1602
40. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., and Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4 (2003) 63-68
41. Tamura M., Asada H., Kondo K., Takahashi M., and Yamanishi K. Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res. 8 (1987) 171-178
42. Vasconcelos P.F., Da Rosa J.F., Da Rosa A.P., Dégallier N., Pinheiro Fde P., and Sá Filho G.C. Epidemiology of encephalitis caused by arbovirus in the Brazilian Amazonia. Rev. Inst. Med. Trop. Sao Paulo 33 (1991) 465-476
43. Weber F., and Elliott R.M. Antigenic drift, antigenic shift and interferon antagonists: how bunyaviruses counteract the immune system. Virus Res. 88 (2002) 129-136
44. Zitzmann K., Brand S., Baehs S., Göke B., Meinecke J., Spöttl G., Meyer H., and Auernhammer C.J. Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells. Biochem. Biophys. Res. Commun. 344 (2006) 1334-1341
45. Zitzmann K., Brand S., De Toni E.N., Baehs S., Göke B., Meinecke J., Spöttl G., Meyer H.H., and Auernhammer C.J. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res. 67 (2007) 5025-5032